Cereno Scientific to attend BIO-Europe in Stockholm, November 4–6, 2024
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that the Company will attend BIO-Europe in Stockholm, November 4–6, 2024.Sten R. Sörensen, CEO, will participate at the well-attended partnering event that attracts global business leaders including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. About BIO-Europe BIO-Europe is the largest partnering event in